COMPANY RESEARCH
ProMIS Neurosciences Inc.
PMN · United States · Healthcare
INSIDER SIGNAL
Insider activity score：51.5 / 100
2 insiders · 2 purchase events · $76k net purchases
US #566 · United States #566
WHY THIS SIGNAL?
Score anatomy
Each bar shows the contribution to the current score; the weights and formula stay unchanged.
Cluster+14.0 / 35
How many distinct insiders bought in the cluster
Purchase size+6.6 / 25
Purchase value relative to company size and liquidity
Role+2.0 / 20
The seniority and relevance of participating insiders
Recency+2.9 / 10
How recently the purchases occurred
Conviction+10.0 / 10
How clearly buying stands out from other activity
What is holding the score back?
- ⚠ Buyer breadth is moderate · fewer than 4 distinct filers
- ⚠ Purchase size is modest relative to the model scale
- ⚠ Insider role contributes less on the current role scale
- ⚠ Purchase activity is becoming less recent
The role contribution follows the US model's seniority ladder.
Buying concentration
60%
Largest buyer：Kirwin Patrick D. · 45k USD
Gross qualified purchase transaction-line value：76k USD
The headline $ total is net buying for the screen; this module uses gross qualified purchase transaction-line values in the filing currency, so the amounts can differ. The current 15-day buyer-breadth input counts distinct buyers; value concentration is disclosed separately here.
This is a ranking under the current US screening rules—not a probability of gain, return forecast, or buy recommendation.
Key purchase quotes (filing currency)
| Filer | Price per unit | Trade date |
|---|---|---|
| Kaplan Johanne | 13.3 USD | Aug 5, 2026 |
| Kirwin Patrick D. | 11.33 USD | Apr 22, 2026 |
Model details
Cluster breakdown (does not change the score)
- 15-day buyer breadth (count)
- 1 distinct reported filers
- Peak time window
- 2026-04-22 to 2026-04-22
- Current breadth input
- 0.400 (capped at 4+ buyers)
- Buyer independence
- Not yet measured; related-party fields are not cross-market comparable
What the filings show
- 🟢 Recent eligible purchase
Kaplan Johanne · 30k USD · Price 13.3 USD · Aug 5, 2026 - 🟢 PDMR purchase
Kirwin Patrick D. · 45k USD · Price 11.33 USD · Apr 22, 2026
Insider vs stock price
2 purchase day(s), 2 purchase line(s) in the 180-day window.
Daily close (USD)Day with an insider purchase
Markers sit on the closing price of the transaction day. They show when insiders traded, not the price they paid or received. "Since" compares that day's close with the last close shown; it is what happened at this company, not a forecast.
If you had followed the purchase
Each row starts on the first close on or after the day a purchase was made public, the earliest a reader could have acted, and ends on the last close shown above.
| Made public | Insiders | In this stock, now | In the median peer stock, now | Difference |
|---|---|---|---|---|
| 2026-04-23 | 1 | 883 −11.7% | 896 −10.4% | −12 −1.2 pts |
| 2026-08-07 | 1 | 653 −34.7% | 917 −8.3% | −263 −26.3 pts |
0 of 2 disclosure day(s) ended ahead of the median peer stock.
Close to close, before costs, taxes, dividends and currency moves. The peer is the median of the other stocks on the same exchange for which this site holds prices (1083 here), not an index. This is what happened, not a forecast: across all purchases on this site the typical gap is close to zero.
Insider timeline
2 insiders bought in the last 180 days, each once and more than 15 days apart.
Tap an item for what it means.
●A purchase: the bigger the dot, the more was bought
Each dot is one insider's purchases on one day. The dot's area follows the amount: the largest purchase here gets the largest dot. Hold the pointer over a dot to see the date and the amount.
Blue line: this share's price, −10.4% over these six months
The closing price of each day, from 10.73 on 2026-04-21 to 9.61 on 2026-10-09. The line has no scale; read it for high and low: a dot on a low stretch was bought cheaply, a dot on a high stretch was not.
Dashed line: the typical stock on the same exchange, −11.1%
Taken from the 1230 other stocks on the same exchange that this site holds prices for. Each is measured from the first day of the window, and every day the middle one is drawn. It starts where the blue line starts, so the gap between the two is the difference: this share −10.4%, the typical one −11.1%, 0.7 points ahead. It is not an index and not a comparison within one industry.
▂Grey bars: companies across United States disclosing purchases each week
A taller bar is a week in which more companies disclosed insider purchases.
This company: insiders buying per month, last 12 months
Nov
Dec
Jan
2Feb
1Mar
1Apr
May
Jun
Jul
1Aug
Sep
Oct
Darker bars are inside the 180-day window above.
Who traded
| Insider | Role | Purchases | Sales | Bought | First purchase | Share price since |
|---|---|---|---|---|---|---|
| Kaplan Johanne | Executive | 1 | — | 30.3k USD | 2026-08-05 | −28.7% |
| Kirwin Patrick D. | Board member | 1 | — | 45.3k USD | 2026-04-22 | −13.5% |
Why this score? · Model details
Priority = 100 × Σ(fixed weight × 0–1 rule-based input)
| Factor | Weight | This company input | Point contribution |
|---|---|---|---|
| 15-day buyer breadth (count) | 35% | 0.400 | 14.0 |
| Qualified-buy size | 25% | 0.264 | 6.6 |
| Role informativeness (inverted) | 20% | 0.900 | 18.0 |
| Recency | 10% | 0.291 | 2.9 |
| Buy/sell conviction | 10% | 1.000 | 10.0 |
This is a heuristic ordering under the current rules, not a calibrated return forecast. It explains why candidates rank differently; the public-filing evidence and data limits are shown below.
BULL VS BEAR
Two readings of this buying
The same filings, read two ways. Each line is a fact stored for this company with the number behind it, and appears only when that number crosses a fixed threshold. Neither side is a forecast and no winner is declared.
Where the evidence comes from
The two kinds of evidence disagree: the purchases themselves carry bull lines (purchase added much to the holding), while share price and trading argue against (price down over six months). No data is held for: company results, company actions.
- The insider purchases themselvesBullpurchase added much to the holding Bearusual level for this company7 checked, under the threshold · 1 missing
- Share price and tradingBearprice down over six months1 checked, under the threshold
- Short sellers1 checked, under the threshold
- Company results2 missing
- Company actionsno data held
Bull case · the buying is informative
- 2 of 2 purchase filings state the shares held before and after. The largest addition to an existing holding took it from 653 to 4,653 shares (+613%). A holding here is one way of owning the shares: directly, or through one named trust or entity.
Bear case · discount it
- Buying at this level is normal here: 3 insiders bought in the previous 180 days and 2 in this one.
- Share price and tradingThe share price is down 24% over six months (three months −25%, one month −28%) and stands 65% below its 52-week high. Insiders have bought into a fall the market has not reversed.
Evidence still missing
- No buyer here has 5 or more completed earlier purchases on record, so there is no track record to weigh.
- The company's market value is not captured, so the purchases cannot be stated as a share of the business or of its trading volume.
- No earnings, margin or cash-flow figures are captured for this company. The latest annual and interim reports are where to check whether the business is improving or deteriorating.
Checked and under the threshold: 9, 1 close to it
- EitherThe latest purchase is 74 days old. Bull up to 14 days, bear from 90. close to the threshold
- BullAt most 1 insider bought within any 15 days. Counted for the bull side from 3.
- BearThe largest buyer accounts for 60% of the value bought. Counted for the bear side from 80%.
- EitherNet purchases of $76k in 180 days. Bull from $1.0M, bear when all purchases total under $25k.
- BearNo insider sale is recorded in the same 180 days.
- BearOver three months the share price changed −25% and the median of 219 Healthcare companies changed −12%: behind by 13 points. Counted for the bear side from 20 points behind.
- BearNone of the 2 purchase filings ticks Form 4's 10b5-1 box.
- BearNo insider filing in the last 180 days opened a hedge on this stock.
- BearFINRA short interest on 2026-09-30 equals 7.1 days of average trading volume, down 0.59% from the previous report. Counted for the bear side from 10 days, or from 10% of the shares outstanding.
Both columns arrange stored facts only. They do not change the insider score or the ranking and are not investment advice.
Signal history
51.5 / 100
Latest recorded score
↓ -2.6 ptssince the first recorded snapshot on 2026-10-09; 9 calendar days observed
- Recorded snapshots
- 7
- First snapshot
- 2026-10-09
There is not yet a 30-calendar-day comparison; earlier scores are not reconstructed. These are raw signal scores saved when each full scoring run completed. They describe changes in research ranking, not price performance or returns.
Why did it change?
Less than 30 days of comparable history is available, so factor movement is not yet decomposed.
Signal score history
Fixed 0–100 scale; dates are spaced by calendar time.
Recent recorded points
- 54.1
- 51.9
- 51.8
- 51.7
- 51.5
View all recorded scores
| Snapshot date | Signal score |
|---|---|
| 2026-10-09 | 54.1 |
| 2026-10-12 | 52.0 |
| 2026-10-13 | 51.9 |
| 2026-10-14 | 51.8 |
| 2026-10-15 | 51.7 |
| 2026-10-16 | 51.6 |
| 2026-10-18 | 51.5 |
Sector context
- Buying breadth
- 4.1% (42 / 1,029 issuers)
- Sector rank
- #8 / 13
This is sector-level research context. It does not affect the Insider Signal or ranking.
Insider profile outcomes
Historical performance following insider filings. The company role is translated below each name while preserving the original title.
- Excess return = stock return − S&P 500 ETF (SPY adjusted close) return over the same period.
- Hit rate = completed events with positive excess return ÷ total completed events.
- Price coverage = valid point-in-time prices ÷ events mature enough for that period.
- Returns start on the first shared trading session on or after publication.
- Small-sample rule: n<5 is shown for transparency and is not scored.
Events are disclosure-level observations; related disclosures published on the same date may share a return path and may not be statistically independent. This research enrichment does not affect the insider score or ranking.
Signal outcomes
Calculated from immutable US ranking snapshots; excess return is stock return minus SPY return. Newly saved snapshots remain pending until each forward horizon matures. This never affects the US score.
| Horizon | Status | Result |
|---|---|---|
| 5D | Awaiting maturity | — |
| 20D | Awaiting maturity | — |
| 60D | Awaiting maturity | — |
| 120D | Awaiting maturity | — |
Market context
PRICE PERFORMANCE
VOLATILITY & LIQUIDITY
- Volatility
- 144.0%
- Beta
- —
- Avg daily volume
- $793,496.1
VALUATION
- Market cap
- —
- P/E
- —
FUNDAMENTALS
- Profit margin
- —
- ROE
- —
- Industry
- —
Prices to 11 Oct 2026: OpenBB/yfinance; volume from price cache (yfinance). It does not affect the insider score or rank.
Insiders' buying price vs the latest close
The latest close in the price history is more than a week old.
Buying size vs market trading
Complete price and volume history is not yet available.
Market-data coverage: 0 verified sessions · Latest session: — · Ratio status: Unavailable
Traded value is estimated as close × shares traded, in major currency units. Includes disclosed qualifying purchases; disclosures may lag. Contractual or planned acquisitions are not necessarily discretionary. Ratios describe relative trading size, not market participation or score contributions.
Regulatory filings
- Insider filing announcement · published 2026-08-07 · trade date 2026-08-05
- Insider filing announcement · published 2026-04-23 · trade date 2026-04-22
- Insider filing announcement · published 2026-03-06 · trade date 2026-03-05
Unfold all 11 filings
- Insider filing announcement · published 2026-08-07 · trade date 2026-08-05
- Insider filing announcement · published 2026-04-23 · trade date 2026-04-22
- Insider filing announcement · published 2026-03-06 · trade date 2026-03-05
- Insider filing announcement · published 2026-03-04 · trade date 2026-03-04
- Insider filing announcement · published 2026-02-23 · trade date 2026-02-19
- Insider filing announcement · published 2026-02-05 · trade date 2026-02-03
- Insider filing announcement · published 2026-02-05 · trade date 2026-02-03
- Insider filing announcement · published 2026-02-05 · trade date 2026-02-03
- Insider filing announcement · published 2026-02-05 · trade date 2026-02-03
- Insider filing announcement · published 2026-02-05 · trade date 2026-02-03
- Insider filing announcement · published 2026-02-05 · trade date 2026-02-03
Results and insider purchases
| Results (8-K) | Bought within 5 sessions | Bought within 20 sessions | Buyers, 20 sessions before |
|---|---|---|---|
| 2026-08-1316:07 ET · after the closeFirst session 2026-08-14 | None | None | 1 |
| 2026-05-1206:45 ET · before the open | None | None | 1 |
| 2026-03-2508:06 ET · before the open | None | 1 · $45.3KKirwin Patrick D. | 1 |
| 2025-11-1207:05 ET · before the open | None | None | 0 |
Results dates are the company's 8-K filings to the SEC under Item 2.02 (results of operations); one filed after the close counts from the next session. Purchases are open-market buys reported on Form 4 (code P), by trade date; a Form 4 can arrive two business days after the trade, so the latest days can still fill in. Facts only; this does not change the score or rank.
Ownership and trading-plan context
| Direct / indirect ownership | Unavailable |
|---|---|
| 10b5-1 filing evidence | Unavailable |
| Evidence retrieved | Unavailable |
These are accession-level filing fields. Unavailable means the evidence was not fetched or parsed; it is never inferred as “No” and does not adjust the US score.
Filing evidence
These are underlying national-feed records from the 365-day window ending on the saved ranking snapshot. The score uses only the latest 180 days; older qualifying equity purchases remain visible for audit but do not enter the current score. The original filer, role, transaction classification, instrument, price, volume, value and source fields are retained. The first three rows are shown; remaining records can be unfolded for audit. Other transaction types are retained but excluded from the score.
Excluded transactions & classification
6 qualifying purchase disclosure(s) · 8 transaction line(s)
Mar 5, 2026Open market purchase
Williams Eugene · Director
Common Shares · 2000.0 shares × 24.4 USD · 48800.0 USD
Open filingMar 4, 2026Open market purchase
Williams Eugene · Director
Common Shares · 2000.0 shares × 24.0 USD · 48000.0 USD
Open filingMar 3, 2026Open market purchase
Williams Eugene · Director
Common Shares · 1000.0 shares × 21.89 USD · 21890.0 USD
Open filingUnfold all 5 remaining filing row(s)
| Transaction date | Published | Filer | Role | Transaction | Instrument | Price (local currency) | Quote currency | Volume | Reported value (local currency) | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-02 | 2026-03-04 | Williams Eugene | Director | Open market purchase | Common Shares | 22.53 USD | USD | 1000.0 | 22530.0 USD | Open filing |
| 2026-02-19 | 2026-02-23 | Kaplan Johanne | Chief Development Officer | Open market purchase | Common Shares | 15.35 USD | USD | 1629.0 | 25005.149999999998 USD | Open filing |
| 2026-02-03 | 2026-02-05 | ABG Management Ltd.; Alex Slanix Paul; Ally Bridge Group (NY) LLC; Ally Bridge MedAlpha Master Fund L.P.; Yu Fan | Director; TenPercentOwner | Open market purchase | Common Shares | 12.13 USD | USD | 700741.0 | 8499988.33 USD | Open filing |
| 2026-04-22 | 2026-04-23 | Kirwin Patrick D. | Director | Open market purchase | Common Shares | 11.33 USD | USD | 4000.0 | 45320.0 USD | Open filing |
| 2026-08-05 | 2026-08-07 | Kaplan Johanne | Chief Development Officer | Open market purchase | Common Shares | 13.3 USD | USD | 2280.0 | 30324.0 USD | Open filing |
Showing 8 of 8 matching raw-feed row(s) from the current 365-day research window. Prices and reported values remain in the filing currency and its major unit (for example, UK pence are parsed as GBP). The screen-level $ aggregate is separately FX-normalised for research ranking, not a trade-date conversion.
Other disclosed transactions · excluded from score
View 5 other transaction(s)
Feb 3, 2026Grant or award
Cashman Neil · Chief Scientific Officer
Common Shares · 4122.0 shares × 12.13 USD · 49999.86 USD
Open filingFeb 3, 2026Grant or award
Kaplan Johanne · Chief Development Officer
Common Shares · 2060.0 shares × 12.13 USD · 24987.800000000003 USD
Open filingFeb 3, 2026Grant or award
Warma Neil K · Chief Executive Officer
Common Shares · 6183.0 shares × 12.13 USD · 74999.79000000001 USD
Open filingUnfold all 2 remaining filing row(s)
| Transaction date | Published | Filer | Role | Transaction | Instrument | Price (local currency) | Quote currency | Volume | Reported value (local currency) | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-02-03 | 2026-02-05 | Milbury Max A. | Other | Grant or award | Common Shares | 12.13 USD | USD | 6595.0 | 79997.35 USD | Open filing |
| 2026-02-03 | 2026-02-05 | Kirwin Patrick D. | Director | Grant or award | Common Shares | 12.13 USD | USD | 3050.0 | 36996.5 USD | Open filing |
Showing 5 of 5 matching raw-feed row(s) from the current 365-day research window. Prices and reported values remain in the filing currency and its major unit (for example, UK pence are parsed as GBP). The screen-level $ aggregate is separately FX-normalised for research ranking, not a trade-date conversion.
Snapshot & identity
- Snapshot date
- 2026-10-18
- Ticker
- PMN
- ISIN
- —
- Sector
- Healthcare
- Industry
- —
Company logos by Parqet
How to read Form 4 transaction codes
| Code | Interpretation | Screen treatment |
|---|---|---|
| P | Open-market / private purchase | Buy evidence when the security is qualifying equity |
| S | Sale | Sell evidence when the security is qualifying equity |
| A | Grant / award | Context only |
| F | Tax-related withholding | Context only |
| M | Option exercise | Context only |
| G | Gift | Context only |
| J / L | Other / non-directional | Context only |
P/S rows for options, warrants, compensation units and debt remain visible for audit but are excluded from equity scores and quotes.